Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Glenmark Pharma gets tentative USFDA nod for Clobetasol Propionate foam to treat Skin ailments

      Glenmark Pharma gets tentative USFDA nod for Clobetasol Propionate foam to treat Skin ailments

      Medical Dialogues Bureau26 Nov 2018 12:21 PM IST
      New Delhi: Glenmark Pharmaceuticals Monday said it has received a tentative nod from the US health regulator for Clobetasol Propionate foam, used to...
      U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million

      U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million

      Medical Dialogues Bureau26 Nov 2018 9:59 AM IST
      ZURICH: Just weeks after Novartis floated the idea that $4-5 million was fair value for its new gene therapy against a deadly neuromuscular disease, a...
      Pricing might be tested with costly eye therapy: Novartis

      Pricing might be tested with costly eye therapy: Novartis

      Medical Dialogues Bureau26 Nov 2018 9:38 AM IST
      ZURICH: Novartis price-setting muscle is about to be tested after it won European Union approval for a blindness-fighting gene therapy whose $850,000...
      Lupin launches ANYA- Indias first chatbot for patients

      Lupin launches ANYA- India's first chatbot for patients

      Medical Dialogues Bureau25 Nov 2018 12:57 PM IST
      Ahmedabad: Pharma major Lupin announced the launch of a chatbot named ‘ANYA’ specially designed to provide medically verified information for...
      Portable Personal Oxygen Cans launched in India

      Portable Personal Oxygen Cans launched in India

      Medical Dialogues Bureau25 Nov 2018 9:55 AM IST
      New Delhi: Gupta Oxygen Pvt. Ltd announced the launch of the first-ever FDA approved canned Oxygen, MyOxy exclusively for the India market.According...
      US appeals court declines J&J bid to stop sales of generic version of Blockbuster cancer drug Zytiga

      US appeals court declines J&J bid to stop sales of generic version of Blockbuster cancer drug Zytiga

      Medical Dialogues Bureau25 Nov 2018 9:24 AM IST
      New Delhi: A U.S. appeals court declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of...
      Indoco Remedies gets two minor observations from USFDA for Goa plants

      Indoco Remedies gets two minor observations from USFDA for Goa plants

      Medical Dialogues Bureau25 Nov 2018 9:07 AM IST
      Mumbai: Drug firm Indoco Remedies on Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants....
      NPPA withdraws the ceiling price of Vitamin A Oral liquid

      NPPA withdraws the ceiling price of Vitamin A Oral liquid

      Medical Dialogues Bureau24 Nov 2018 3:09 PM IST
      New Delhi: Through a recent notice, National Pharmaceutical Pricing Authority(NPPA) has decided to withdraw the ceiling price of Vitamin A Oral liquid...
      Novartis Luxturna Gene Therapy for restoring Eyesight in Rare retinal diseases gets European Approval

      Novartis Luxturna Gene Therapy for restoring Eyesight in Rare retinal diseases gets European Approval

      Medical Dialogues Bureau24 Nov 2018 1:24 PM IST
      Luxturna is first gene therapy for a genetic disease approved in both the U.S. and EU. Luxturna is first and only gene therapy approved in EU for...
      Samsung Electronics issues apology for factory cancer cases

      Samsung Electronics issues apology for factory cancer cases

      Medical Dialogues Bureau24 Nov 2018 1:18 PM IST
      South Korean activist group Sharps claims around 200 workers have fallen ill after working at Samsung plants and 70 of them have died subsequently.New...
      Roots and shoots: China seeks new markets for ancient medicines

      Roots and shoots: China seeks new markets for ancient medicines

      Medical Dialogues Bureau24 Nov 2018 9:24 AM IST
      New Delhi: Shanghai, Nov 21, 2018 -A crowd gathers at a Shanghai hospital, queuing for remedies made with plant mixtures and animal parts including...
      AstraZeneca sells infant drug rights to Sobi for $1.5 bln upfront

      AstraZeneca sells infant drug rights to Sobi for $1.5 bln upfront

      Medical Dialogues Bureau24 Nov 2018 9:00 AM IST
      LONDON: AstraZeneca took another step to refocus its portfolio on priority projects on Tuesday by selling U.S. rights to a treatment for a serious...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok